Clínic Barcelona
Health Topics

Tofacitinib: new drug approved for the treatment of patients with ulcerative colitis

Ulcerative colitis is a chronic inflammatory disease that affects the colonic mucosa. There is no curative treatment. Instead, patients must take medication to control the inflammation over the course of their lives. There are some patients whose condition cannot be sufficiently controlled by the drugs currently available. For them, the new treatment with tofacitinib could be an alternative.

Picture: Francisco Avia
Keep reading about:

Related news